MAIA Biotechnology, Inc.
Telomere Targeting Immunotherapies for Cancer
Chicago, United States · Founded 2025
- Headquarters
- Chicago, Illinois
- Employees
- 11–50
- Founded
- 2025
- Website
- maiabiotech.com
About
MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Ateganosine (THIO), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity, driving its development pipeline of second-generation telomere targeting agents.
Summary
MAIA Biotechnology, Inc. is a Biotech company based in Chicago, United States, founded in 2025.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/maia-biotechnology-inc"><img src="https://indexed.vc/api/badge/company/maia-biotechnology-inc" alt="MAIA Biotechnology, Inc. on Indexed.vc" width="260" height="76" /></a>